Birdwatch Note
2023-11-24 15:24:22 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
本件は事実を誤認しているかまたは歪曲していると考えられます。 POTSについては、EMA(European Medicines Agency)が明確に否定しています。 https://www.ema.europa.eu/en/news/hpv-vaccines-ema-confirms-evidence-does-not-support-they-cause-crps-pots 日本でも名古屋スタディが様々な接種後症状との因果関係を否定しています。 http://www.med.nagoya-cu.ac.jp/kouei.dir/ns_Nagoya%20Stduy_Papillomavirus%20Research2018.pdf また、スウェーデン等では子宮頸がんの撲滅にめどが立ったとして以下のような宣言をしています。 https://www.who.int/europe/news/item/13-09-2022-the-cancer-we-can-eliminate---who-europe-urges-member-states-to-consign-cervical-cancer-to-history#:~:text=Sweden%20predicts%20that%20cervical%20cancer%20could%20be%20eliminated%20in%20that%20country%205%20years%20from%20now%2C%20meaning%20they%20would%20see%20less%20than%204%20new%20cases%20per%20100%20000%20women%20each%20year
Written by 3BC7C51111B8ABEEE7F0248AFBF189D4DF3A8D1691E3AA3072986DC45C51449D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1727958864023502885
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1728072072465952918
- noteId - 1728072072465952918
- participantId -
- noteAuthorParticipantId - 3BC7C51111B8ABEEE7F0248AFBF189D4DF3A8D1691E3AA3072986DC45C51449D Participant Details
- createdAtMillis - 1700839462762
- tweetId - 1727958864023502885
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 本件は事実を誤認しているかまたは歪曲していると考えられます。 POTSについては、EMA(European Medicines Agency)が明確に否定しています。 https://www.ema.europa.eu/en/news/hpv-vaccines-ema-confirms-evidence-does-not-support-they-cause-crps-pots 日本でも名古屋スタディが様々な接種後症状との因果関係を否定しています。 http://www.med.nagoya-cu.ac.jp/kouei.dir/ns_Nagoya%20Stduy_Papillomavirus%20Research2018.pdf また、スウェーデン等では子宮頸がんの撲滅にめどが立ったとして以下のような宣言をしています。 https://www.who.int/europe/news/item/13-09-2022-the-cancer-we-can-eliminate---who-europe-urges-member-states-to-consign-cervical-cancer-to-history#:~:text=Sweden%20predicts%20that%20cervical%20cancer%20could%20be%20eliminated%20in%20that%20country%205%20years%20from%20now%2C%20meaning%20they%20would%20see%20less%20than%204%20new%20cases%20per%20100%20000%20women%20each%20year
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-11-24 15:24:22 UTC (1700839462762) |
1969-12-31 23:59:59 UTC (-1) |
2023-11-25 04:30:11 UTC (1700886611750) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-11-24 19:19:20 -0600 | Rating Details | |
2023-11-24 18:14:46 -0600 | Rating Details | |
2023-11-24 18:12:51 -0600 | Rating Details | |
2023-11-24 17:02:13 -0600 | Rating Details | |
2023-11-24 17:00:03 -0600 | Rating Details | |
2023-11-24 16:41:57 -0600 | Rating Details | |
2023-11-24 16:24:03 -0600 | Rating Details | |
2023-11-24 15:37:02 -0600 | Rating Details | |
2023-11-24 13:29:38 -0600 | Rating Details | |
2023-11-24 12:08:36 -0600 | Rating Details | |
2023-11-24 11:44:41 -0600 | Rating Details | |
2023-11-24 11:10:40 -0600 | Rating Details | |
2023-11-24 10:52:49 -0600 | Rating Details | |
2023-11-24 10:45:15 -0600 | Rating Details | |
2023-11-24 10:12:00 -0600 | Rating Details | |
2023-11-24 22:56:52 -0600 | Rating Details | |
2023-11-24 22:28:06 -0600 | Rating Details | |
2023-11-24 20:08:04 -0600 | Rating Details | |
2023-11-26 00:59:48 -0600 | Rating Details | |
2023-11-25 23:10:06 -0600 | Rating Details | |
2023-11-27 13:00:55 -0600 | Rating Details | |
2023-11-25 00:16:48 -0600 | Rating Details | |
2023-11-24 23:42:14 -0600 | Rating Details | |
2023-11-24 23:31:45 -0600 | Rating Details | |
2023-11-24 22:08:16 -0600 | Rating Details | |
2023-11-24 21:11:04 -0600 | Rating Details | |
2023-11-24 20:57:29 -0600 | Rating Details | |
2023-11-24 20:14:00 -0600 | Rating Details | |
2023-11-24 19:01:26 -0600 | Rating Details | |
2023-11-24 18:49:49 -0600 | Rating Details | |
2023-11-24 18:16:43 -0600 | Rating Details | |
2023-11-24 17:52:38 -0600 | Rating Details | |
2023-11-24 17:37:15 -0600 | Rating Details | |
2023-11-24 17:03:07 -0600 | Rating Details | |
2023-11-24 15:21:01 -0600 | Rating Details | |
2023-11-24 15:17:07 -0600 | Rating Details | |
2023-11-24 14:50:08 -0600 | Rating Details | |
2023-11-24 14:31:36 -0600 | Rating Details | |
2023-11-24 14:10:21 -0600 | Rating Details | |
2023-11-24 10:51:11 -0600 | Rating Details | |
2023-11-24 10:32:32 -0600 | Rating Details | |
2023-11-24 09:51:50 -0600 | Rating Details | |
2023-11-24 17:52:21 -0600 | Rating Details | |
2023-11-24 11:36:34 -0600 | Rating Details | |
2024-06-02 06:24:20 -0500 | Rating Details | |
2024-05-25 20:58:08 -0500 | Rating Details | |
2024-05-31 02:55:21 -0500 | Rating Details | |
2024-06-08 08:12:15 -0500 | Rating Details | |
2024-07-11 17:52:12 -0500 | Rating Details | |
2024-08-19 17:40:54 -0500 | Rating Details | |
2024-08-19 08:47:21 -0500 | Rating Details | |
2024-08-14 21:31:32 -0500 | Rating Details | |
2024-08-14 03:29:51 -0500 | Rating Details | |
2024-08-08 00:44:05 -0500 | Rating Details | |
2024-08-02 06:29:52 -0500 | Rating Details | |
2024-08-13 14:41:03 -0500 | Rating Details | |
2024-08-05 04:18:35 -0500 | Rating Details | |
2024-09-21 10:37:17 -0500 | Rating Details | |
2024-09-11 22:34:05 -0500 | Rating Details | |
2024-08-30 06:57:44 -0500 | Rating Details |